Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature

Bone Marrow Transplantation volume 27, pages 101–105 (2001)Cite this article

Abstract

Congenital erythropoietic porphyria (CEP) is a rare autosomal recessive disorder of porphyrin metabolism in which the genetic defect is the deficiency of uroporphyrinogen III cosynthase (UIIIC). Deficiency of this enzyme results in an accumulation of high amounts of uroporphyrin I in all tissues leading to hemolytic anemia, splenomegaly, erythrodontia, bone fragility, exquisite photosensitivity and mutilating skin lesions. We describe the case of a 23-month-old boy who was cured of his CEP by a matched-sibling allogeneic bone marrow transplant, and review the published clinical experience regarding transplantation in this disease. He is alive and disease-free 15 months post transplant. All of his disease manifestations except for the erythrodontia have resolved. His UIIIC level and stool and erythrocyte porphyrin metabolites have almost completely corrected. He is the sixth child reported to be cured of this disease by stem cell transplantation, five cases being long-term survivors. If patients with this disease have an HLA-matched sibling, then stem cell transplantation should be strongly considered because this is currently the only known curative therapy. Bone Marrow Transplantation (2001) 27, 101–105.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Fritsch C, Bolsen K, Ruzicka T, Goerz G . Congenital erythropoietic porphyria J Amer Ac Derm 1997 36: 594–610

    Article  CAS  Google Scholar 

  2. Pierini AM . Rare metabolic disorders: porphyrias. In: Schachner LA, Hansen RC (eds) Pediatric Dermatology McGraw-Hill: New York 1988 1086–1095

    Google Scholar 

  3. Schmid R, Schwartz S, Watson CJ . Porphyrin content of bone marrow and liver in the various forms of porphyria AMA Arch Intern Med 1954 93: 167–190

    Article  CAS  Google Scholar 

  4. Menagh F, Reyner CE . Hydroa aestivale: congenital porphyria Arch Dermatol 1951 63: 518–519

    Article  CAS  Google Scholar 

  5. Stich W . Die kongenitale Porphyrie, eine erythropatische haemolytische Anamie (Porphyrocytose) Schweiz Med Wochenschr 1958 41: 1012–1014

    Google Scholar 

  6. Weremowicz I . Congenital porphyria with erythrodontia, splenomegaly, and anemia in two sisters Pol Tyg Lek 1954 9: 550–2; 585–589

    Google Scholar 

  7. Gross S . Hematologic studies on erythropoietic porphyria: a new case with severe hemolysis, chronic thrombocytopenia and folic acid deficiency Blood 1964 23: 762–775

    CAS  PubMed  Google Scholar 

  8. Rank JM, Straka JG, Weimer MK et al. Hematin therapy in late onset congenital erythropoietic porphyria Br J Haematol 1990 75: 617–622

    Article  CAS  Google Scholar 

  9. Gray CH, Neuberger A . Effect of splenectomy in a case of congenital erythropoietic porphyria Lancet 1952 1: 851–854

    Article  CAS  Google Scholar 

  10. Kaufman BM, Bickers HR, Rayne J et al. Congenital erythropoietic porphyria: report of a case Br J Dermatol 1967 79: 210–220

    Article  CAS  Google Scholar 

  11. Rosenthal IM, Lipton EL, Asrow G . Effect of splenectomy on porphyria erythropoietica Pediatrics 1969 15: 663–675

    Google Scholar 

  12. Simard H, Barry A, Villaneuve B et al. Porphyrie erythropoietique congenitale Can Med Assoc J 1972 107: 1002–1004

    Google Scholar 

  13. Piomelli S, Poh-Fitzpatrick MB, Seaman C et al. Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions New Engl J Med 1986 314: 1029–1031

    Article  CAS  Google Scholar 

  14. Pierach CA . Hematin therapy for the porphyric attack Semin Liver Dis 1982 2: 125–131

    Article  CAS  Google Scholar 

  15. Watson CJ, Bossenmaier I, Cardinal RA et al. Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria Proc Natl Acad Sci USA 1974 71: 278–282

    Article  CAS  Google Scholar 

  16. Watson CJ . Haematin and porphyria (editorial) New Engl J Med 1975 293: 605–607

    Article  CAS  Google Scholar 

  17. Kramer S, Viljoen E, Meyer AM et al. The anemia of erythropoietic porphyria with the first description of the disease in an elderly patient Br J Haematol 1965 11: 666–675

    Article  CAS  Google Scholar 

  18. Pain RW, Welch FW, Woodrofe AJ et al. Erythropoietic uroporphyria of Gunther first presenting at 58 years with positive family studies Br Med J 1975 3: 621–623

    Article  CAS  Google Scholar 

  19. Chatterji AK, Ghosh SK, Chatterjea LB . Observation of therapeutic aspects of porphyria erythropoietica with special reference to steroid therapy J Assoc Phys India 1963 11: 937–941

    CAS  Google Scholar 

  20. Pimstone NR, Gandhi SN, Mukerji SK . Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria New Engl J Med 1987 316: 390–393

    Article  CAS  Google Scholar 

  21. Lischner HW . Cholestyramine and porphyrin-binding Lancet 1966 2: 1079–1080

    Article  Google Scholar 

  22. Tanigawa K, Namba H, Ohtsuru A et al. Plasmasorbent therapy with activated charcoal column for congenital erythropoietic porphyria Dermatology 1994 188: 329–330

    Article  CAS  Google Scholar 

  23. Moore MR, McColl KEL, Fitzsimons EJ et al. The porphyrias Blood Rev 1990 4: 88–96

    Article  CAS  Google Scholar 

  24. Guarini L, Piomelli S . Hydroxyurea in congenital erythropoietic porphyria New Engl J Med 1994 330: 1091–1092

    Article  CAS  Google Scholar 

  25. Kauffman L, Evans DI, Stevens RF, Weinkove C . Bone marrow transplantation for congenital erythropoietic porphyria Lancet 1991 337: 1510–1511

    Article  CAS  Google Scholar 

  26. Zix-Kieffer I, Langer B, Eyer D et al. Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease) Bone Marrow Transplant 1996 18: 217–220

    CAS  PubMed  Google Scholar 

  27. Thomas C, Ged C, Nordmann Y et al. Correction of congenital erythropoietic porphyria by bone marrow transplantation J Pediatr 1996 129: 453–455

    Article  CAS  Google Scholar 

  28. Lagarde C, Hamel-Teillac D, DeProst Y et al. Allogeneic bone marrow transplantation in congenital erythropoietic porphyria Ann Dermatol Venereol 1998 125: 114–117

    CAS  PubMed  Google Scholar 

  29. Tezcan I, Xu W, Gurgey A et al. Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation Blood 1992 92: 4053–4058

    Google Scholar 

  30. Schultz JH . Ein Fall von Pemphigus leprosus, compliciert durch Lepra visceralis Greifswald 1874 863

  31. Gunther H . Die haematoporphyriae Deutsche Arch Klin Med 1911 105: 89–146

    Google Scholar 

  32. Romeo G, Levin EY . Uroporphyrinogen III cosynthase in human congenital erythropoietic porphyria Proc Natl Acad Sci USA 1969 63: 856–863

    Article  CAS  Google Scholar 

  33. Mazurier F, Moreau-Gaudry F, Salesse S et al. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria J Inher Metab Dis 1997 20: 247–257

    Article  CAS  Google Scholar 

  34. Moreau-Gaudry F, Mazurier F, Benisidhoum M et al. Metabolic correction of congenital erythropoietic porphyria by retrovirus-mediated gene transfer into Epstein–Barr virus-transformed B-cell lines Blood 1995 85: 1449–1453

    CAS  PubMed  Google Scholar 

  35. Moreau-Gaudry F, Ged C, Barbot C et al. Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transfer Hum Gene Ther 1995 6: 13–20

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics and Dermatology, Northwestern University Medical School and Children's Memorial Hospital, Chicago, IL, USA

    PH Shaw, AJ Mancini, D Brown & M Kletzel

  2. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

    JP McConnell

Authors
  1. PH Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. AJ Mancini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. JP McConnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Kletzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shaw, P., Mancini, A., McConnell, J. et al. Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature. Bone Marrow Transplant 27, 101–105 (2001). https://doi.org/10.1038/sj.bmt.1702738

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702738

Keywords

This article is cited by

Search

Advanced search

Quick links